Seeking Alpha

Health science firm Nordion (NDZ +0.6%) ticks higher today on an upgrade at RBC Capital to...

Health science firm Nordion (NDZ +0.6%) ticks higher today on an upgrade at RBC Capital to Sector Perform on the back of its better than expected FQ1 earnings report yesterday, with a price target of $8 a share. The company also announced it had initiated a review of strategic alternatives with a view to enhancing shareholder value and creating new opportunities. Read more on earnings here: Earnings Call Transcript.
Comments (1)
  • NDZ is worth much more than $8... more likely $10-12 on the basis of the sum of its parts, all of which would be better utilized within other corporate structures.
    7 Mar 2013, 02:25 PM Reply Like
DJIA (DIA) S&P 500 (SPY)